Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17881236rdf:typepubmed:Citationlld:pubmed
pubmed-article:17881236lifeskim:mentionsumls-concept:C0733755lld:lifeskim
pubmed-article:17881236lifeskim:mentionsumls-concept:C1130454lld:lifeskim
pubmed-article:17881236lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:17881236lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:17881236lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:17881236lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:17881236lifeskim:mentionsumls-concept:C0597413lld:lifeskim
pubmed-article:17881236pubmed:issue24lld:pubmed
pubmed-article:17881236pubmed:dateCreated2007-10-22lld:pubmed
pubmed-article:17881236pubmed:abstractTextNucleoside transporter inhibitors have potential therapeutic applications as anticancer, antiviral, cardioprotective, and neuroprotective agents. S(6)-(4-nitrobenzyl)mercaptopurine riboside (NBMPR) is a prototype inhibitor of the human equilibrative nucleoside transporter (hENT1), and is a high affinity ligand with a K(d) of 0.1-1.0 nM. We have synthesized and flow cytometrically evaluated the binding affinity of a series of novel C(2)-purine position substituted analogs of NBMPR at the hENT1. The aim of this research was to understand the substituent requirements at the C(2)-purine position of NBMPR. Structure-activity relationships (SAR) indicate that increasing the steric bulk at the C(2)-purine position of NBMPR led to a decrease in binding affinity of these ligands at the hENT1. New high affinity inhibitors were identified, with the best compound, 2-fluoro-4-nitrobenzyl mercaptopurine riboside (7), exhibiting a K(i) of 2.1 nM. This information, when coupled with the information obtained from other structure-activity relationship studies should prove useful in efforts aimed at modeling the NMBPR and analogs pharmacophore of hENT1 inhibitors.lld:pubmed
pubmed-article:17881236pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:languageenglld:pubmed
pubmed-article:17881236pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:citationSubsetIMlld:pubmed
pubmed-article:17881236pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17881236pubmed:statusMEDLINElld:pubmed
pubmed-article:17881236pubmed:monthDeclld:pubmed
pubmed-article:17881236pubmed:issn1464-3391lld:pubmed
pubmed-article:17881236pubmed:authorpubmed-author:BuolamwiniJoh...lld:pubmed
pubmed-article:17881236pubmed:authorpubmed-author:GupteAmolAlld:pubmed
pubmed-article:17881236pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17881236pubmed:day15lld:pubmed
pubmed-article:17881236pubmed:volume15lld:pubmed
pubmed-article:17881236pubmed:ownerNLMlld:pubmed
pubmed-article:17881236pubmed:authorsCompleteYlld:pubmed
pubmed-article:17881236pubmed:pagination7726-37lld:pubmed
pubmed-article:17881236pubmed:dateRevised2011-9-26lld:pubmed
pubmed-article:17881236pubmed:meshHeadingpubmed-meshheading:17881236...lld:pubmed
pubmed-article:17881236pubmed:meshHeadingpubmed-meshheading:17881236...lld:pubmed
pubmed-article:17881236pubmed:meshHeadingpubmed-meshheading:17881236...lld:pubmed
pubmed-article:17881236pubmed:meshHeadingpubmed-meshheading:17881236...lld:pubmed
pubmed-article:17881236pubmed:meshHeadingpubmed-meshheading:17881236...lld:pubmed
pubmed-article:17881236pubmed:meshHeadingpubmed-meshheading:17881236...lld:pubmed
pubmed-article:17881236pubmed:meshHeadingpubmed-meshheading:17881236...lld:pubmed
pubmed-article:17881236pubmed:meshHeadingpubmed-meshheading:17881236...lld:pubmed
pubmed-article:17881236pubmed:meshHeadingpubmed-meshheading:17881236...lld:pubmed
pubmed-article:17881236pubmed:year2007lld:pubmed
pubmed-article:17881236pubmed:articleTitleNovel C2-purine position analogs of nitrobenzylmercaptopurine riboside as human equilibrative nucleoside transporter 1 inhibitors.lld:pubmed
pubmed-article:17881236pubmed:affiliationDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Sciences Center, 847 Monroe Avenue Suite 327, Memphis, TN 38163, USA.lld:pubmed
pubmed-article:17881236pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17881236pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:17881236lld:chembl